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Age at presentation
Newman[1] demonstrated that the overall mean age 
at which African women present with breast cancer 
is 35 - 45 years, 10 - 15 years earlier than their 
Caucasian counterparts.[2] A 3-year retrospective 
review of 374 breast cancer patients in Kenya showed a median 
age of 44 years at presentation;[2] only 26 of 250 (10.4%) had early 
breast cancer. Of 250 patients reviewed by Adebamowo et al.,[3] 
72.8% presented with advanced breast cancer (Manchester stage III 
and IV disease). In South Africa, no national data exist. However, 
individual breast centres increasingly report their experience with 
early breast cancer.[4-6] 
Stigma
Stigma refers to the attachment of negative connotations to a 
diagnosis. The Livestrong Foundation Report determined that stigma 
is an important part of cancer diagnosis.[7] Studies in African 
American women show that fatalism, stigma and privacy are some of 
the key factors influencing non-attendance in regions where national 
screening programmes exist.[8] These are accentuated in low-resource 
environments where facilities do not exist. 
Patients in low-resource settings face unique challenges in having 
to cope with breast cancer. Not only do they have to deal with the 
emotional impact of a cancer diagnosis, but also with the additional 
constraints of poverty, lack of access to care and dependence on their 
partners for financial support.
A study of 81 women with breast cancer in Nigeria showed that 
married African women have significant emotional, physical and 
social problems following primary treatment of breast cancer.[9] Of 
the 81 patients included in the study, 38.3% had divorced or separated 
3 years after therapy compared with the national average of 2.6%.
Survivorship
The American College of Surgeons classifies survivorship as ≥5 
years since the initial diagnosis of cancer.[10] Little has been written 
on survivorship in low- and middle-income countries owing to the 
frequent lack of national cancer registries and poor patient follow-up. 
Hayanga and Newman[11] described a high incidence/mortality ratio 
of breast cancer in women on the African continent, 1:2 compared 
with 1:5 among white American women. While these low ratios may 
be due to late presentation, more vigilant follow-up of patients in the 
immediate post-treatment phase could potentially identify other key 
contributing factors. 
The quality of life (QOL) of patients who survive cancer may 
be positively or negatively affected.[12] QOL is defined as the 
perception of well-being that arises from an individual’s satisfaction 
or dissatisfaction with those aspects of life that are important to 
the person.[13] QOL may differ depending on the stage of breast 
cancer, the treatment modalities and the survivorship after the initial 
treatment phase. Breast cancer patients are at an increased risk of 
developing physical and psychological conditions that affect their 
overall QOL.[14] Lack of knowledge of recovery patterns and evidence-
based guidelines for follow-up care may result in persistent and late 
effects of cancer treatment.[14]
Uncertainty remains a major concern among patients with 
breast cancer and has a strong impact on their coping behaviour 
and QOL.[13] Uncertainty is defined as the inability of a person 
to understand the meaning of illness-related events such as 
the disease process, treatment, or hospitalisation.[15] It develops 
if the patient has no understanding of the disease process, either 
due to lack of knowledge, complex treatment regimens or the 
unpredictable nature of the disease. This may be exacerbated in low-
income settings where resource constraints may hamper effective 
management of tumours. Concerns over disease recurrence, side-
effects of treatment and threat of death and dying continue to have 
significant implications on a patient’s functional status.[16]
Health-related QOL encompasses the physical, psychological and 
social functioning of patients.[17] The QOL model for cancer patients, 
which was initially proposed by Ferrell,[18] consists of four dimensions, 
i.e. physical, psychological, social and spiritual well-being. Physical 
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dimensions infer that the patient can continue with activities of daily 
living. The psychological domain emphasises a sense of control over the 
disease and its threat to life. The social domain refers to an individual’s 
ability to re-integrate and maintain meaningful relationships, whereas 
the spiritual domain requires that an individual maintains hope and an 
understanding of their disease.[18]
QOL may be determined by the health, professional and family 
environment.[19] These factors may be further modified as a result of 
the disease and its treatment.[20] QOL plays a very important role in 
breast cancer survivors, and the overall physical, psychosocial and 
spiritual considerations need to be addressed. Physical limitations, 
such as the impaired ability to return to work, and psychological 
distress and uncertainty over the future, have implications on the 
individual’s QOL.
Survivorship in resource-poor settings
Survivorship in developing countries constitutes a newly emerging 
concept. With the transition to survivorship come new concerns 
along the Ferrell domains,[18] all of which may warrant interpretation 
in a regional context. Breast cancer survivors encounter unique 
socioeconomic challenges and a lack of an established support system. 
There are very little data on breast cancer survivorship in low-
income countries. Therefore, not much is known about factors 
affecting the population, and the absence of a national cancer register 
makes patient follow-up difficult. 
Solutions 
Regardless of the patient’s environment, the US-based Institute 
of Medicine of the national academies recommends that a 
comprehensive care plan be developed for cancer survivors 
(Tables 1 and 2). There is a need to optimise ways to ameliorate 
the overall level of suffering and to remove the stigma attached 
to breast cancer. Practical strategies in low-resource environments 
include increasing breast cancer awareness, promoting cancer 
advocacy, strengthening the survivorship base by providing positive 
role models who have survived cancer, and the development of an 
effective cancer navigation system. 
Breast cancer awareness is an attempt to increase knowledge and 
reduce stigma. It aims to encourage women to be more aware of their 
breasts, thereby promoting earlier presentation and diagnosis. Breast 
cancer advocacy refers to the strategies employed predominantly 
by breast cancer survivors and well-wishers towards treatment and 
support. Survivorship refers to holistic living, and cancer navigation 
to the development of a support and referral system to ensure that all 
cancer patients receive optimal care.
Breast cancer awareness
Breast health awareness can contribute towards reducing the stigma 
of the diagnosis and increasing earlier presentation. Stockton et al.[21] 
in the 1980s were able to demonstrate an earlier presentation of 
breast disease due to an increase in media campaigns. Health-seeking 
behaviour of communities is very important. Lack of community 
involvement has led to initiatives not being readily adopted, as 
illustrated by Pisani et al.[22] in Asia. Innovative strategies are required 
to define the barriers to health-seeking behaviour and to try to 
overcome them. 
 Community healthcare workers may be used to determine 
barriers to access to healthcare. Studies by Abuidris et al.[23] in 
Sudan, using healthcare workers who were educated in breast 
health promotion and then returned to their communities, helped 
to decrease the stigma of breast pathology and provide a forum 
for safe communication of healthcare problems with familiar 
people. Similar studies in Bangladesh by Ginsburg et al.,[24] where 
community healthcare workers shared testimonials of successfully 
treated patients with the general public, helped to decrease the 
stigma of breast cancer.
Community ‘buy in’ is key and a synergistic dialogue should 
be maintained between communities and breast cancer awareness 
organisers. Non-governmental organisations (NGOs) play an active 
role in breast cancer awareness. In developed countries, organisations 
such as the Susan G Komen Foundation and the Avon Foundation 
have increased awareness of breast cancer internationally. In South 
Africa, a number of breast cancer NGOs exist. The recent creation of 
a national coalition of these NGOs should be commended, as it is a 
model designed to effect change. 
Creation of a survivorship model
Involving key cancer survivors in a community can contribute 
towards removing the stigma of cancer. Positive role models with 
whom patients can identify can go a long way towards removing the 
myths surrounding cancer – in Uganda, studies have demonstrated 
the benefit of using patients’ spouses and cancer survivors.[25]
Survivorship navigation
Alongside the use of positive role models, the creation of a successful 
navigation programme has dramatically increased attendance in 
low-resource areas. Raj et al.[26] described a decrease in the stage at 
presentation and an improvement in clinical treatment adherence 
when using navigators in underserved areas of the USA, which may 
reflect the situation in low-resource environments. The adaptation of 
a survivorship navigation model to our local scenario could have a 
positive impact in the region. The purpose of survivorship navigation 
is to assist with mitigating barriers that survivors may experience in 
accessing survivorship services and attaining a good QOL.[27] The 
use of community healthcare workers for navigation has also been 
successfully demonstrated by Ginsburg et al.[24] in Bangladesh.
Call for cancer advocacy
There is a role for cancer advocacy. It employs a multipronged 
approach with different arms of advocacy contributing to the overall 
advancement of cancer knowledge. Educational advocacy involves 
Table 1. Essential components of survivorship care*
1. Prevention of recurrent and new cancers, and other late effects
2.  Surveillance for cancer spread, recurrence, or second cancers; 
assessment of medical and psychosocial late effects
3. Intervention for consequences of cancer and its treatment
4.  Co-ordination between specialists and primary care providers to 
ensure that all the survivors’ health needs are met
*Adapted from Hewitt M, et al.[28]
Table 2. Essential components of phycosocial survivorship 
care*
1.  Identify psychosocial difficulties and develop care plans with 
patients
2. Connect patients with appropriate services
3. Support patients in managing their illnesses
4. Co-ordinate psychosocial and biomedical care
5.  Provide follow-up assessment to monitor and evaluate outcomes 
and to make appropriate alterations in care plans
*Adapted from Adler N, et al.[29]
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improving cancer awareness among patients, their families and 
the public by using different modalities, such as the print media 
and radio. Social gatherings such as weddings, fundraising events, 
preplanned town meetings or worship gatherings can all be employed 
as platforms where this knowledge can be disseminated.[28] 
Community outreach advocacy involves a bidirectional dialogue 
between the target community and cancer advocates. An assessment 
is done to determine the cancer needs of the community and how 
advocates can address these concerns. Dissemination of information 
back to a community and working with key stakeholders help to 
develop an effective community advocacy model. The community 
feels engaged in the process, and advocates avoid imposing their 
perceived plans on a community.[28]
Support advocacy involves trying to address the concerns 
of patients and families living with cancer. This is of particular 
importance, especially in newly diagnosed patients, who may 
frequently be bewildered by the implications of a cancer diagnosis. 
The African Organisation for Research and Treatment in Cancer 
(AORTIC) support advocacy working group defines cancer support 
as connecting patients, families and caregivers for help, hope, 
and inspiration throughout cancer management and need.[28] 
This support attempts to ensure holistic living of patients and 
could involve emotional support, financial advice, and nutritional 
recommendations. Support advocacy aims to address all of Ferrell’s 
domains of concern.[18] 
Research advocacy involves ensuring that community-relevant 
research is carried out. This demands a continuous assessment of the 
priorities of cancer patients and partnerships with scientists for active 
involvement in grant proposals and research. It may involve sitting on 
the medical ethics/institutional review boards of research facilities to 
ensure that the patients’ voice is heard. 
Political advocacy involves liaising with stakeholders to ensure that 
policy affecting cancer is enacted, and collaborating with legislators to 
ensure that policies that facilitate optimal cancer care are prioritised. 
Fundraising advocacy involves innovative ways of raising funds to 
support local cancer initiatives, which may involve local businesses 
or community stakeholders.[28]
All these arms of advocacy are aimed at increasing the visibility of 
cancer patients’ concerns. The founding of an African consortium of 
cancer advocates in 2011 and their conclusions for furthering cancer 
care in the region are a step in the right direction (Table 3). The 
recent creation of a national breast cancer advocacy group, Advocates 
for Breast Cancer (ABC), marks a promising new chapter in the 
approach to cancer care in South Africa. 
As clinicians, we have frequently had a ‘hands-off ’ approach to 
advocacy. As part of a multidisciplinary approach, we are opinion 
leaders in our field and can do more towards encouraging cancer 
advocacy. Perhaps, with the increasing burden of cancer, it may be 
time to review for whom the cancer advocacy bell tolls. 
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Table 3. Recommendations for successful advocacy in Africa*
1.    Education and training for advocates, including areas of grant 
writing and networking
2.    Local, state, national, and global collaborations to share resources
3.    Creating community awareness for greater acknowledgement of 
cancer and its treatment and impact
4.   Lobbying for each country to have a cancer registry
5.    Putting pressure on government to develop a national policy and 
plan for the prevention and control of cancer
6.    Development of a funding model that will enhance collaboration 
among cancer non-governmental organisations rather than 
competition for scarce resources
7.    Co-ordination of cancer funding nationally to eliminate 
disparities that exist in different regions, especially with regard to 
access to appropriate treatments, fair distribution of services and 
more effective service delivery
8.    Control of the high cost of cancer treatment to make it more 
readily available in state and private sectors
9.    Development of national policies and infrastructure to manage 
the burden of cancer in Africa
10.  Development of a platform for addressing cancer advocacy 
in Africa, led by experienced and committed African cancer 
advocates
*Adapted from Odedina FT, et al.[30] 
